SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001554795-14-000341
Filing Date
2014-05-05
Accepted
2014-05-05 11:53:51
Documents
5
Effectiveness Date
2014-05-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A gnbt5514sch14a.htm DEFR14A 13489
3 GRAPHIC p1.jpg GRAPHIC 54881
4 GRAPHIC p2.jpg GRAPHIC 103728
5 GRAPHIC p3.jpg GRAPHIC 24006
6 GRAPHIC p4.jpg GRAPHIC 117429
  Complete submission text file 0001554795-14-000341.txt   428419
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: DEFR14A | Act: 34 | File No.: 000-25169 | Film No.: 14812162
SIC: 2834 Pharmaceutical Preparations